ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 660029 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 660029; 2) Community: the network communities that were significantly associated with the response to NSC 660029; 3) Molecule: the relationships between components within communities and NSC 660029; 4) MDR: the compounds that were significantly associated with the NSC 660029.

NSC Compound Enrichment Correlation
NSC 142493 Null 0.0186186224062458 0.22334292
NSC 268993 Deferoxamine hydrochloride 0.0186186224062458 0.48609299
NSC 291926 Null 0.0186186224062458 0.1208029
NSC 301477 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-4-O-methyl-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)- 0.0186186224062458 0.54485986
NSC 343499 CI-921: amsacrine derivative 0.0186186224062458 0.60681386
NSC 364830 Camptothecin Derivative 0.0186186224062458 0.35261279
NSC 409304 Null 0.0186186224062458 0.35085957
NSC 49488 Null 0.0186186224062458 0.21684229
NSC 636092 Pyridine-3,5-dicarboxamide, 1,4-dihydro-2,6-dimethyl- 4-[4-(dimethylamino)phenyl]-N,N'-diphenyl- 0.0186186224062458 0.004343522
NSC 644221 Null 0.0186186224062458 0.55179073
Total:69  Current:29    [First] [Prev] [Next] [Last]